Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic IVD Tests for Personalized Precision Medicine in Cancer

28 Jun 2019

Abstract excerpt

Epigenetic alterations play a key role in the initiation and progression of cancer. Therefore, it is possible to use epigenetic marks as biomarkers for predictive and precision medicine in cancer. Precision medicine is poised to impact clinical practice, patients and healthcare systems. The objective of this review is to provide an overview of the epigenetic testing landscape in cancer by examining commercially...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Radiomics and Machine Learning in Medical Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31316555
DOI: 10.3389/fgene.2019.00621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic IVD Tests for Personalized Precision Medicine in CancerPMID 31316555Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future PerspectivesSemantic proximity Read ↗

Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsySemantic proximity Read ↗

Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.Semantic proximity Read ↗

Precision medicine for cancer with next-generation functional diagnosticsSemantic proximity Read ↗

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuumSemantic proximity Read ↗

Personalized medicine using DNA biomarkers: a reviewSemantic proximity Read ↗

DNA Methylation As a Clinical Marker in OncologySemantic proximity Read ↗

Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer DetectionSemantic proximity Read ↗

DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer TypesSemantic proximity Read ↗

Epigenetic biomarkers for human cancer: the time is now.Semantic proximity Read ↗

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.